Recently, S100A8/A9 has emerged as a promising biomarker for sepsis, and it is a pathogenic molecule with both pro-inflammatory and immunosuppressive properties, primarily found in myeloid cells, including neutrophils and monocytes (Wang et al., 2023). This evidence concerns the gene IGKV1D-22 and Sepsis.